FMR LLC 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 09:03 am Purchase |
2024-02-08 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR LLC | 5,313,294 7.338% |
2,621,240 (+97.37%) |
Filing |
| 2023-02-09 10:59 am Sale |
2023-02-09 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR LLC | 2,692,054 6.014% |
-537,912 (-16.65%) |
Filing |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR LLC | 3,229,966 7.499% |
100,532 (+3.21%) |
Filing |
| 2021-02-08 10:23 am Purchase |
2021-02-05 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR LLC | 3,129,434 7.499% |
3,129,434 (New Position) |
Filing |